Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Thursday, January 30, 2020

AMR - Where are the Professional Societies?

I have written two blogs relevant to today’s discussion. In one , I decry the absence of guidelines from professional s...

Thursday, January 9, 2020

BARDA, Paratek and Pull Incentives

In December, BARDA and Paratek announced a large award to Paratek for the development of omadacycline (NUZYRA ® ) for the preven...

Monday, December 30, 2019

Melinta and the $2.6 billion

The widely predicted bankruptcy of Melinta has arrived. This was the result of meager sales of four antibiotics, unsustainable debt and ...

Tuesday, December 17, 2019

A Year of Too Little Too Late

Looking back on 2019, it has been a year of climate change for antibiotics. If you are easily depressed – maybe you don’t want to continue ...

Monday, December 2, 2019

Antibiotics - Europe or a Tapestry of Nations?

I spend a great deal of time in Europe. For drug regulation, in terms of approval for market authority, there is a centralized European ag...

Sunday, November 24, 2019

Antibiotics - Innovation or Clinical Utility?

Lately I have become intrigued with the word, innovation. Innovation is used a criterion for funding grants, for status in reviews of our...

Wednesday, November 20, 2019

The CDC's Report on Antibiotic Resistant Threats in the US

This is Antibiotic Awareness week. The US Centers for Disease Control just released their new report , Antibiotic Resistant Threats in...

View web version

Powered by Blogger.